Myeloid Therapeutics Securities Corp
300 Technology Sq Ste 203
Cambridge, MA 02139
Myeloid Therapeutics Securities Corp is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapeutics for myeloid-related diseases.
With a focus on cutting-edge research and technology, the company aims to address unmet medical needs and improve patient outcomes in the field of myeloid disorders.
Generated from their business information
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


